期刊文献+

缬沙坦对高血压早期肾损害患者的疗效观察 被引量:3

The Observation of the Therapeutic Effect of Valsartan on the Essential Hypertension Patients with Early Renal Injury
下载PDF
导出
摘要 目的研究缬沙坦对高血压早期肾损害的疗效。方法选取110名高血压并出现早期肾损害患者,口服给予缬沙坦治疗8周,观察、评价缬沙坦降压疗效的同时,收集病人尿样,采用放免法测定治疗前后的尿微量白蛋白(MA)水平。结果给予缬沙坦治疗后,早期高血压肾损害患者的收缩压、舒张压及尿MA水平均显著降低(P<0.01)。结论对高血压早期肾损害患者,缬沙坦可有效降压及保护肾脏功能。 Objective To analyze the therapeutic effect of valsartan on essential hypertension patients with early renal injury.Methods 110 patients with essential hypertension and early kidney injury were treated with valsartan for 8 weeks,the therapeutic effect of the decrease of the blood pressure were observed,at the same time,the urinary microamount albumin(MA) levels were determined by using radioimmunity method before and after valsartan treatment.Results After valsartan treatment,there was significant decrease of the systolic pressure,diastolic pressure and the urinary MA levels in essential hypertension patients with early renal injury.Conclusion Valsartan can control blood pressure and protect the renal function effectively.
作者 李德环 赵琛
出处 《青岛医药卫生》 2011年第2期96-98,共3页 Qingdao Medical Journal
关键词 早期肾损害 原发性高血压 缬沙坦 Early renal injury Essential hypertension Valsartan
  • 相关文献

参考文献8

二级参考文献22

  • 1Razzaque M S, Taguchi T. Cellular and molecular events leading to renal tubulointerstitial fibrosis[J].Med Electron Microse, 2002,35 : 68-80.
  • 2Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis[J]. Am J Pathol, 2001,159 : 1465-1475.
  • 3Yang J,Dai C, Liu Y. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction[J]. Am J Pathol, 2003,163 : 621-632.
  • 4Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis[J]. J Am Soc Nephrol, 2002,13 : 96-107.
  • 5Kalluri R, Neilson E G. Epithelial mesenchymal transition and its implications for fibrosis[J]. J Clin Invest, 2003,112 : 1776-1784.
  • 6Neilson E G. Mechanisms of disease: fibroblasts--a new look at an old problem[J]. Nat Clin Pract Nephrol, 2006,2:101-108.
  • 7Yamaguchi I, Lopez-Guisa J M, Cai X, Collins S J, Okamura D M, Eddy A A. Endogenous urokinase lacks antifibrotie activity during progressive renal injury[J]. Am J Physiol Renal Physiol,2007,293:F12-F19.
  • 8Kellner D, Chen J, Richardson I, Seshan S V, El Chaar M, Vaughan E D Jr,et al. Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction[J].J Urol, 2006,176 : 806-812.
  • 9Abe S,Amagasaki Y,Iyori S,et al.Significance of tubuloin-terstitial lesion in biopsy specimens of glomerulonephritic patients[J].Am J Nephrol,1989,9(1):30
  • 10Healy E,Brady HR.Role of tubule epithelial cells in the pathogenesis of tubulointerstitial fibrosis induced by glomerular disease[J].Curr Opin Nephrol Hypertens,1998,7(5):525

共引文献31

同被引文献48

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部